Results 1 to 10 of about 419,059 (195)

The 100 Days Mission: a perspective on accelerating vaccine manufacturing for future pandemics [PDF]

open access: yesBMC Global and Public Health
The “100 Days Mission” aims to compress the timeline for delivering safe and effective vaccines in response to future pandemics. Here, we present insights from Pfizer leaders involved in the COVID-19 vaccine effort on key enablers for rapid large-scale ...
B. Adam Williams   +8 more
doaj   +2 more sources

Do Public Announcements of Drug Development Events Influence a Drug Company’s Market Value? A Study on Pfizer [PDF]

open access: yesJournal of Library and Information Studies, 2022
The circulation of money in the global pharmaceutical market is substantial and has been increasing annually. Moreover, the high requirements for new drugs and the procedures for verifying the quality of drugs are increasingly complex; thus, successful ...
Yu-Han Tsao, Chun-Chieh Wang
doaj   +1 more source

Effectiveness and adverse effects of astrazeneca and pfizer COVID-19 vaccines among medical students in Oman: A comparative study

open access: yesBiomedical and Biotechnology Research Journal, 2023
Background: Immunization against severe acute respiratory syndrome coronavirus 2 became necessary to control the menace of COVID-19. However, the safety of COVID-19 vaccines must be monitored continuously.
Mohan Bilikallahalli Sannathimmappa   +5 more
doaj   +1 more source

Impact of previous infection and body mass index on interferon-gamma and immunoglobulin G level generated against three types of vaccines available in Iraq

open access: yesBiomedical and Biotechnology Research Journal, 2022
Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj   +1 more source

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2021
The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative ...
Khalid Hajissa, Ali Mussa
doaj   +1 more source

A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18

open access: yesAvicenna Journal of Medicine, 2022
This is a care report of a 16-year-old-male who developed de novo minimal change disease following the second dose of the Pfizer vaccine. The patient developed sudden onset edema and 10 kg weight gain. He had nephrotic range proteinuria with normal renal
Mohamad Nour Alhosaini
doaj   +1 more source

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson

open access: yesHuman Vaccines & Immunotherapeutics, 2022
The novel coronavirus outbreak was declared a pandemic in March 2020. We are reviewing the COVID-19 vaccines authorized for use in the United States by discussing the mechanisms of action, administration, side effects, and efficacy of vaccines developed ...
Rikin Patel   +4 more
doaj   +1 more source

The Efficacy and Safety of Heterologous Immunization with Pfizer-BioNTech (Pfizer) to Individuals Who Have Completed A Primary Vaccination Schedule with Sinopharm (BBibp-CorV)

open access: yesJournal of Pure and Applied Microbiology, 2023
The aim of this study was to examine the effectiveness and potential adverse reactions when providing a different Pfizer-BioNTech booster shot to 235 volunteers who had previously received the BBIBP-CorV Sinopharm primary vaccination series.
Nawfal R. Hussein   +3 more
doaj   +1 more source

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias [PDF]

open access: yes, 2015
Background Pulmonary hypertension (PH) is a common finding in patients with chronic fibrosing idiopathic interstitial pneumonias (IIP). Little is known about the response to pulmonary vasodilator therapy in this patient population.
Behr, Juergen   +19 more
core   +10 more sources

Home - About - Disclaimer - Privacy